Annual Cost Of Goods Sold
$184.67 M
-$14.63 M-7.34%
December 31, 2023
Summary
- As of February 7, 2025, PCRX annual cost of goods sold is $184.67 million, with the most recent change of -$14.63 million (-7.34%) on December 31, 2023.
- During the last 3 years, PCRX annual cost of goods sold has risen by +$67.34 million (+57.40%).
- PCRX annual cost of goods sold is now -7.34% below its all-time high of $199.29 million, reached on December 31, 2022.
Performance
PCRX Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cost Of Goods Sold
$38.86 M
-$5.40 M-12.20%
September 30, 2024
Summary
- As of February 7, 2025, PCRX quarterly cost of goods sold is $38.86 million, with the most recent change of -$5.40 million (-12.20%) on September 30, 2024.
- Over the past year, PCRX quarterly cost of goods sold has dropped by -$886.00 thousand (-2.23%).
- PCRX quarterly cost of goods sold is now -37.23% below its all-time high of $61.92 million, reached on December 31, 2022.
Performance
PCRX Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Cost Of Goods Sold
$178.23 M
-$886.00 K-0.49%
September 30, 2024
Summary
- As of February 7, 2025, PCRX TTM cost of goods sold is $178.23 million, with the most recent change of -$886.00 thousand (-0.49%) on September 30, 2024.
- Over the past year, PCRX TTM cost of goods sold has dropped by -$20.66 million (-10.39%).
- PCRX TTM cost of goods sold is now -16.02% below its all-time high of $212.24 million, reached on March 31, 2023.
Performance
PCRX TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cost Of Goods Sold Formula
COGS = Beginning Inventory + Purchases − Ending Inventory
PCRX Cost Of Goods Sold Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.3% | -2.2% | -10.4% |
| 3 y3 years | +57.4% | +7.7% | +22.9% |
| 5 y5 years | +112.6% | +7.7% | +22.9% |
PCRX Cost Of Goods Sold Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.3% | +31.7% | -37.2% | +7.7% | -16.0% | +27.1% |
| 5 y | 5-year | -7.3% | +73.0% | -37.2% | +74.2% | -16.0% | +67.8% |
| alltime | all time | -7.3% | +1404.3% | -37.2% | +1743.6% | -16.0% | +6455.1% |
Pacira BioSciences Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $38.86 M(-12.2%) | $178.23 M(-0.5%) |
| Jun 2024 | - | $44.26 M(-6.7%) | $179.12 M(-2.2%) |
| Mar 2024 | - | $47.42 M(-0.6%) | $183.06 M(-0.9%) |
| Dec 2023 | $184.67 M(-7.3%) | $47.69 M(+20.0%) | $184.67 M(-7.2%) |
| Sep 2023 | - | $39.75 M(-17.5%) | $198.89 M(-5.2%) |
| Jun 2023 | - | $48.21 M(-1.7%) | $209.82 M(-1.1%) |
| Mar 2023 | - | $49.02 M(-20.8%) | $212.24 M(+6.5%) |
| Dec 2022 | $199.29 M(+42.1%) | $61.92 M(+22.2%) | $199.29 M(+13.0%) |
| Sep 2022 | - | $50.68 M(+0.1%) | $176.39 M(+10.0%) |
| Jun 2022 | - | $50.63 M(+40.3%) | $160.36 M(+10.6%) |
| Mar 2022 | - | $36.07 M(-7.5%) | $144.98 M(+3.4%) |
| Dec 2021 | $140.25 M(+19.5%) | $39.01 M(+12.6%) | $140.25 M(+2.7%) |
| Sep 2021 | - | $34.65 M(-1.7%) | $136.54 M(+3.5%) |
| Jun 2021 | - | $35.25 M(+12.4%) | $131.89 M(+10.9%) |
| Mar 2021 | - | $31.35 M(-11.2%) | $118.94 M(+1.4%) |
| Dec 2020 | $117.33 M(+9.9%) | $35.30 M(+17.7%) | $117.33 M(+3.0%) |
| Sep 2020 | - | $29.99 M(+34.5%) | $113.93 M(+7.2%) |
| Jun 2020 | - | $22.30 M(-25.0%) | $106.24 M(-2.7%) |
| Mar 2020 | - | $29.73 M(-6.8%) | $109.14 M(+2.3%) |
| Dec 2019 | $106.71 M(+22.9%) | $31.90 M(+43.0%) | $106.71 M(+8.0%) |
| Sep 2019 | - | $22.30 M(-11.5%) | $98.79 M(+3.4%) |
| Jun 2019 | - | $25.20 M(-7.7%) | $95.55 M(+4.7%) |
| Mar 2019 | - | $27.30 M(+13.9%) | $91.26 M(+5.1%) |
| Dec 2018 | $86.84 M(-1.2%) | $23.98 M(+25.8%) | $86.84 M(+3.2%) |
| Sep 2018 | - | $19.07 M(-8.8%) | $84.16 M(+1.0%) |
| Jun 2018 | - | $20.92 M(-8.6%) | $83.32 M(-3.4%) |
| Mar 2018 | - | $22.89 M(+7.5%) | $86.22 M(-1.9%) |
| Dec 2017 | $87.92 M(-20.2%) | $21.29 M(+16.8%) | $87.91 M(-2.6%) |
| Sep 2017 | - | $18.23 M(-23.4%) | $90.24 M(-21.6%) |
| Jun 2017 | - | $23.81 M(-3.1%) | $115.17 M(+0.7%) |
| Mar 2017 | - | $24.58 M(+4.1%) | $114.41 M(+3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $110.10 M(+53.3%) | $23.62 M(-45.3%) | $110.10 M(+4.0%) |
| Sep 2016 | - | $43.15 M(+87.2%) | $105.91 M(+34.6%) |
| Jun 2016 | - | $23.05 M(+13.7%) | $78.66 M(+5.5%) |
| Mar 2016 | - | $20.28 M(+4.4%) | $74.54 M(+3.8%) |
| Dec 2015 | $71.84 M(-7.2%) | $19.43 M(+22.2%) | $71.84 M(+0.6%) |
| Sep 2015 | - | $15.90 M(-16.0%) | $71.38 M(-5.9%) |
| Jun 2015 | - | $18.93 M(+7.7%) | $75.87 M(-1.3%) |
| Mar 2015 | - | $17.58 M(-7.3%) | $76.89 M(-0.7%) |
| Dec 2014 | $77.44 M(+41.4%) | $18.97 M(-7.0%) | $77.44 M(+0.8%) |
| Sep 2014 | - | $20.39 M(+2.2%) | $76.85 M(+7.9%) |
| Jun 2014 | - | $19.95 M(+10.1%) | $71.25 M(+15.8%) |
| Mar 2014 | - | $18.13 M(-1.4%) | $61.51 M(+12.3%) |
| Dec 2013 | $54.77 M(+70.4%) | $18.38 M(+24.2%) | $54.77 M(+18.9%) |
| Sep 2013 | - | $14.79 M(+44.8%) | $46.07 M(+13.6%) |
| Jun 2013 | - | $10.21 M(-10.3%) | $40.56 M(+9.5%) |
| Mar 2013 | - | $11.39 M(+17.8%) | $37.03 M(+15.2%) |
| Dec 2012 | $32.14 M(+92.0%) | $9.67 M(+4.1%) | $32.14 M(+10.6%) |
| Sep 2012 | - | $9.29 M(+38.9%) | $29.07 M(+25.6%) |
| Jun 2012 | - | $6.68 M(+2.9%) | $23.14 M(+18.2%) |
| Mar 2012 | - | $6.50 M(-1.6%) | $19.57 M(+16.9%) |
| Dec 2011 | $16.74 M(+36.4%) | $6.60 M(+96.6%) | $16.74 M(+36.7%) |
| Sep 2011 | - | $3.36 M(+7.8%) | $12.25 M(-1.7%) |
| Jun 2011 | - | $3.12 M(-15.1%) | $12.46 M(+2.2%) |
| Mar 2011 | - | $3.67 M(+74.0%) | $12.20 M(-0.6%) |
| Dec 2010 | $12.28 M(-0.2%) | $2.11 M(-41.0%) | $12.28 M(-10.0%) |
| Sep 2010 | - | $3.57 M(+25.4%) | $13.65 M(+6.7%) |
| Jun 2010 | - | $2.85 M(-23.9%) | $12.79 M(+28.7%) |
| Mar 2010 | - | $3.75 M(+7.7%) | $9.94 M(+60.4%) |
| Dec 2009 | $12.30 M(-29.6%) | $3.48 M(+27.9%) | $6.20 M(+127.9%) |
| Sep 2009 | - | $2.72 M | $2.72 M |
| Dec 2008 | $17.46 M | - | - |
FAQ
- What is Pacira BioSciences annual cost of goods sold?
- What is the all time high annual cost of goods sold for Pacira BioSciences?
- What is Pacira BioSciences annual cost of goods sold year-on-year change?
- What is Pacira BioSciences quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Pacira BioSciences?
- What is Pacira BioSciences quarterly cost of goods sold year-on-year change?
- What is Pacira BioSciences TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Pacira BioSciences?
- What is Pacira BioSciences TTM cost of goods sold year-on-year change?
What is Pacira BioSciences annual cost of goods sold?
The current annual cost of goods sold of PCRX is $184.67 M
What is the all time high annual cost of goods sold for Pacira BioSciences?
Pacira BioSciences all-time high annual cost of goods sold is $199.29 M
What is Pacira BioSciences annual cost of goods sold year-on-year change?
Over the past year, PCRX annual cost of goods sold has changed by -$14.63 M (-7.34%)
What is Pacira BioSciences quarterly cost of goods sold?
The current quarterly cost of goods sold of PCRX is $38.86 M
What is the all time high quarterly cost of goods sold for Pacira BioSciences?
Pacira BioSciences all-time high quarterly cost of goods sold is $61.92 M
What is Pacira BioSciences quarterly cost of goods sold year-on-year change?
Over the past year, PCRX quarterly cost of goods sold has changed by -$886.00 K (-2.23%)
What is Pacira BioSciences TTM cost of goods sold?
The current TTM cost of goods sold of PCRX is $178.23 M
What is the all time high TTM cost of goods sold for Pacira BioSciences?
Pacira BioSciences all-time high TTM cost of goods sold is $212.24 M
What is Pacira BioSciences TTM cost of goods sold year-on-year change?
Over the past year, PCRX TTM cost of goods sold has changed by -$20.66 M (-10.39%)